Birdwatch Archive

Birdwatch Note

2024-10-02 08:36:13 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

レプリコンワクチンでシェディングなどという現象は起きません。 またレプリコンワクチン「コスタイベ」が日本で承認されるに至った背景には、複数の臨床試験と非臨床試験の試験結果により、レプリコンワクチンが従来のワクチンと比較しても良好な予防効果を持ち、かつ十分な安全性が確保されていることが明らかになったとされています。 https://newspicks.com/news/10551966/body/

Written by D7A3BA93AB464C3619BF19A06DEEEC6CF1E9AFAE70B90D9D52109AB3CDAB4E0E
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841374210800980387

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1841396759370891284
  • noteId - 1841396759370891284
  • participantId -
  • noteAuthorParticipantId - D7A3BA93AB464C3619BF19A06DEEEC6CF1E9AFAE70B90D9D52109AB3CDAB4E0E
  • createdAtMillis - 1727858173587
  • tweetId - 1841374210800980387
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • レプリコンワクチンでシェディングなどという現象は起きません。 またレプリコンワクチン「コスタイベ」が日本で承認されるに至った背景には、複数の臨床試験と非臨床試験の試験結果により、レプリコンワクチンが従来のワクチンと比較しても良好な予防効果を持ち、かつ十分な安全性が確保されていることが明らかになったとされています。 https://newspicks.com/news/10551966/body/

Note Ratings

rated at rated by
2024-10-02 18:37:53 -0500 Rating Details
2024-10-02 17:55:23 -0500 Rating Details
2024-10-02 17:43:10 -0500 Rating Details
2024-10-02 17:33:16 -0500 Rating Details
2024-10-02 16:11:51 -0500 Rating Details
2024-10-02 15:56:10 -0500 Rating Details
2024-10-02 15:53:04 -0500 Rating Details
2024-10-02 13:04:55 -0500 Rating Details
2024-10-02 11:25:26 -0500 Rating Details
2024-10-02 11:17:24 -0500 Rating Details
2024-10-02 09:40:27 -0500 Rating Details
2024-10-02 09:40:15 -0500 Rating Details
2024-10-02 09:14:34 -0500 Rating Details
2024-10-02 09:07:38 -0500 Rating Details
2024-10-02 08:47:27 -0500 Rating Details
2024-10-02 08:42:46 -0500 Rating Details
2024-10-02 08:34:41 -0500 Rating Details
2024-10-02 08:32:26 -0500 Rating Details
2024-10-02 08:27:04 -0500 Rating Details
2024-10-02 08:21:48 -0500 Rating Details
2024-10-02 08:11:05 -0500 Rating Details
2024-10-02 07:36:49 -0500 Rating Details
2024-10-02 07:33:13 -0500 Rating Details
2024-10-02 07:17:55 -0500 Rating Details
2024-10-02 07:15:16 -0500 Rating Details
2024-10-02 07:11:19 -0500 Rating Details
2024-10-02 07:00:17 -0500 Rating Details
2024-10-02 06:32:47 -0500 Rating Details
2024-10-02 06:13:05 -0500 Rating Details
2024-10-02 05:53:47 -0500 Rating Details
2024-10-02 05:39:31 -0500 Rating Details
2024-10-02 05:37:36 -0500 Rating Details
2024-10-02 05:26:32 -0500 Rating Details
2024-10-02 05:23:29 -0500 Rating Details
2024-10-02 05:17:18 -0500 Rating Details
2024-10-02 05:07:49 -0500 Rating Details
2024-10-02 05:03:57 -0500 Rating Details
2024-10-02 05:02:36 -0500 Rating Details
2024-10-02 04:54:23 -0500 Rating Details
2024-10-02 04:43:56 -0500 Rating Details
2024-10-02 04:43:06 -0500 Rating Details
2024-10-02 04:36:55 -0500 Rating Details
2024-10-02 04:36:22 -0500 Rating Details
2024-10-02 04:29:35 -0500 Rating Details
2024-10-02 04:28:31 -0500 Rating Details
2024-10-02 04:25:19 -0500 Rating Details
2024-10-02 04:23:58 -0500 Rating Details
2024-10-02 04:18:56 -0500 Rating Details
2024-10-02 04:06:24 -0500 Rating Details
2024-10-02 04:04:49 -0500 Rating Details
2024-10-02 04:00:35 -0500 Rating Details
2024-10-02 04:00:02 -0500 Rating Details
2024-10-02 03:59:19 -0500 Rating Details
2024-10-02 03:48:54 -0500 Rating Details
2024-10-02 03:48:17 -0500 Rating Details
2024-10-02 03:43:21 -0500 Rating Details
2024-10-02 03:42:53 -0500 Rating Details
2024-10-02 03:42:11 -0500 Rating Details
2024-10-02 03:40:04 -0500 Rating Details
2024-10-03 18:24:53 -0500 Rating Details
2024-10-03 17:56:48 -0500 Rating Details
2024-10-03 12:06:29 -0500 Rating Details
2024-10-03 11:26:58 -0500 Rating Details
2024-10-03 08:55:25 -0500 Rating Details
2024-10-03 04:44:00 -0500 Rating Details
2024-10-03 04:05:11 -0500 Rating Details
2024-10-03 00:10:27 -0500 Rating Details
2024-10-02 22:45:55 -0500 Rating Details
2024-10-02 11:37:30 -0500 Rating Details
2024-10-02 11:02:45 -0500 Rating Details
2024-10-02 08:34:33 -0500 Rating Details
2024-10-02 07:08:41 -0500 Rating Details
2024-10-02 05:42:53 -0500 Rating Details
2024-10-02 04:40:06 -0500 Rating Details
2024-10-02 04:17:17 -0500 Rating Details
2024-10-02 04:07:15 -0500 Rating Details
2024-10-02 04:04:24 -0500 Rating Details
2024-10-02 03:59:11 -0500 Rating Details
2024-10-02 03:53:30 -0500 Rating Details
2024-10-02 03:51:26 -0500 Rating Details
2024-10-02 03:41:26 -0500 Rating Details
2024-10-02 18:14:02 -0500 Rating Details
2024-10-02 17:02:06 -0500 Rating Details
2024-10-02 08:15:47 -0500 Rating Details
2024-10-02 07:11:34 -0500 Rating Details
2024-10-02 05:14:09 -0500 Rating Details
2024-10-02 04:21:50 -0500 Rating Details
2024-10-02 04:20:27 -0500 Rating Details
2024-10-02 04:19:23 -0500 Rating Details
2024-10-02 03:57:13 -0500 Rating Details
2024-10-02 03:46:45 -0500 Rating Details
2024-10-02 03:45:50 -0500 Rating Details
2024-10-03 02:39:24 -0500 Rating Details
2024-10-02 23:01:02 -0500 Rating Details
2024-10-02 16:26:30 -0500 Rating Details
2024-10-02 10:37:21 -0500 Rating Details
2024-10-02 08:53:59 -0500 Rating Details
2024-10-02 06:12:11 -0500 Rating Details
2024-10-03 19:14:34 -0500 Rating Details
2024-10-26 13:21:27 -0500 Rating Details
2024-10-30 13:45:23 -0500 Rating Details